FDA Lists Major Compliance Findings From Its Drug Audits in 2023

This week the FDA released its annual report on compliance inspections listing key observations made by its inspectors, giving current trends in non-compliance activities and related FDA enforcement activities. The report provides an overall picture of what FDA inspectors look for at the facilities they are auditing to help others prepare for the FDA inspections. … Read more

FDA Creates a Tool to Make it Easy to Find GMP Guidelines 

FDA publishes a lot of guidelines to assist the industry, on its website. But since FDA’s website has more than a million pages, by some accounts, finding all relevant documents on the FDA’s website is no easy task. To make it easier for GMP manufacturers, the FDA published a new page on its website with … Read more

FDA Releases Several MoCRA Support Tools

Under the Modernization of Cosmetic Regulations Act of 2022 (MoCRA), cosmetic manufacturers are subject to increased registration and GMP compliance rules. This week FDA released several electronic tools to assist cosmetic manufacturers in submitting information required under MoCRA. These include electronic forms for providing manufacturer information, product listing, and other commitments expected to be submitted … Read more

Compounding Pharmacies Fight the Stigma of Unapproved Drug Manufacturing

Last year’s biggest drug was semaglutide, the weight-loss drug marketed by Novo Nordisk as Wegovy and Ozempic. Both these drugs are currently in shortage which means that compounding pharmacies are allowed to compound them from active ingredients on prescription, and they have been. Novo pushed back by filing patent infringement lawsuits against a few compounding … Read more

FDA Released 21 New Guidance Documents in the Last 15 Days of 2023

It has become an annual ritual for FDA to release several new Guidance Documents in the last few days of a year and true to that, the FDA did exactly that by releasing 21 new Guidance Documents in the last 13 days of December. Many of these Guidance Documents affect critical aspects of FDA regulated … Read more

The Year of ChatGPT: Its Effects on Healthcare and FDA Regulations 

Last year was unquestionably the Year of ChatGPT. It affected all aspects of life, including healthcare and FDA-regulated products. ChatGPT did for artificial intelligence (AI), what iPhones did for smartphones 15 years ago. Although several AI-based medical products have been used in medicine and even approved by the FDA in the last few years, no … Read more

Electronic Submission of PMA to the FDA

Starting this week, the Premarket Approval (PMA) applications can also be submitted electronically to the FDA using the eSTAR format. FDA released an update of the eSTAR template which now includes the PMA application. It is critical to review the utility of the eSTAR template for creating FDA-acceptable PMA applications. The eSTAR template is a … Read more

All Applicable Clinical Trials Are Already Compliant with Clinicaltrials.gov: FDA 

According to the FDA, all clinical trials that should be compliant with the clinicaltrials.gov regulations are already compliant. In a surprising blog this week, the FDA Commissioner pointed out the major flaw in the complaint that most clinical trials are not compliant with clinical trial reporting requirements by stating that only 15% of the trials … Read more

CAR-T Therapies Cause Cancer? FDA Investigates Multiple Reports of Link

This week FDA made an explosive announcement that there are reports of new cancers in patients treated with several approved CAR-T therapies. Although the FDA added the disclaimer that the benefit of these treatments still outweighs the risk of the same, the news is sure to rattle patients who received these treatments over the last … Read more